Prescription drug · ANDA
Mometasone Furoate NDC 45802-119
Mometasone furoate 1 mg/g · Ointment · Topical · Padagis Israel Pharmaceuticals Ltd
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 45802-119-37 | 45802011937 | 1 TUBE in 1 CARTON (45802-119-37) / 15 g in 1 TUBEMarketed from Jul 18, 2008 | |
| 45802-119-42 | 45802011942 | 1 TUBE in 1 CARTON (45802-119-42) / 45 g in 1 TUBEMarketed from Jul 30, 2008 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mometasone Furoate
- Generic name (nonproprietary)
- mometasone furoate
- Active ingredients
- Mometasone furoate — 1 mg/g
- Dosage form
- Ointment
- Route
- Topical
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 076067
- Marketing start
- Listing expires
- Other FDA classes
- Corticosteroid Hormone Receptor Agonists (Mechanism)Corticosteroid Hormone Receptor Agonists (Mechanism)
- Identifiers
- Product ID 45802-119_7184c06c-6e26-4f05-bc97-7e3bcb266405SPL ID 7184c06c-6e26-4f05-bc97-7e3bcb266405SPL set ID d986282f-da3c-43b6-a3f6-40886d4a1915RxCUI 151029UNII 04201GDN4R
- Pharmacologic class
- Corticosteroid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N445802011937followed by a unit qualifier and the quantityPackage 45802-0119-37. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Mometasone furoate ointment is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age or older. Mometasone furoate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in adults and pediatric patients 2 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.